Trial intelligence / Profile preview

Buffered vs. Unbuffered Lidocaine in Symptomatic Irreversible Pulpitis

NCT05227300Phase 4Completed

Sponsor
Indiana University
Start
Feb 2022
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sodium bicarbonate in irreversible pulpitis, sponsored by Indiana University. Started Feb 2022; status: completed.

02

Drugs

sodium bicarbonate
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on NCT05227300.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05227300.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call